A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta Thalassemia
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Age: Between 18 - 65 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required